TXNIP Regulates Peripheral Glucose Metabolism in Humans
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Type 2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and action. Impaired glucose uptake in skeletal muscle is believed to be one of the earliest features in the natural history of T2DM, although underlying mechanisms remain obscure. METHODS AND FINDINGS: We combined human insulin/glucose clamp physiological studies with genome-wide expression profiling to identify thioredoxin interacting protein (TXNIP) as a gene whose expression is powerfully suppressed by insulin yet stimulated by glucose. In healthy individuals, its expression was inversely correlated to total body measures of glucose uptake. Forced expression of TXNIP in cultured adipocytes significantly reduced glucose uptake, while silencing with RNA interference in adipocytes and in skeletal muscle enhanced glucose uptake, confirming that the gene product is also a regulator of glucose uptake. TXNIP expression is consistently elevated in the muscle of prediabetics and diabetics, although in a panel of 4,450 Scandinavian individuals, we found no evidence for association between common genetic variation in the TXNIP gene and T2DM. CONCLUSIONS: TXNIP regulates both insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle. Combined with recent studies that have implicated TXNIP in pancreatic beta-cell glucose toxicity, our data suggest that TXNIP might play a key role in defective glucose homeostasis preceding overt T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 TXNIP Expression in Individuals with Diabetes or at Risk for Developing Diabetes (A) TXNIP expression levels from individuals with NGT, IGT, or T2DM, using data from our previously published microarray study [18]. * p < 0.02; ** p < 0.01, Mann-Whitney U-test. (B) TXNIP expression levels from NGT individuals with family history of T2DM (FH+) or without (FH−), as well as individuals with T2DM, using data from a previously published microarray study [27]. * p < 0.03, Mann-Whitney U-test.](https://figures.cochat.ai/paper-figures/ca9ef16bc19d42259bbcc36f2b7c4340/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-2.jpg)

![Figure 4 Insulin-Mediated Glucose Uptake Versus TXNIP Expression This relationship is shown for individuals with NGT, IGT, and T2DM. Linear regression parameters are indicated for each of the groups. Data are from our previously published microarray study [18].](https://figures.cochat.ai/paper-figures/c969253506d74789b5b972b212cc68b2/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-4.jpg)

![Figure 6 Pattern of Genetic Variation at the TXNIP Locus Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D′ values were calculated with 95% confidence intervals. D′ plot for each square depicts the magnitude of linkage disequilibrium for a pair of markers, red indicates high D′ with high logarithm of odds (LOD) score, while white indicates low D′ with low LOD score, and blue indicates high D′ with low LOD score.](https://figures.cochat.ai/paper-figures/1e45333953bb4d3999d14146d7c357ce/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-6.jpg)
![Figure 7 Model of TXNIP Regulation and Action and Its Potential Role in the Pathogenesis of T2DM (A) Previous studies have shown that glucose induces the expression of TXNIP in a variety of cells and tissues. In this study we show that insulin suppresses the expression of TXNIP. Moreover, we have found that forced expression of TXNIP results in reduced glucose uptake, while inhibition of TXNIP enhances glucose uptake. These results suggest that TXNIP serves as a glucose- and insulin-sensitive homeostatic switch that regulates glucose uptake in the periphery. (B) Role of TXNIP in glucose toxicity in the β-cell and in impaired glucose uptake in the periphery. Insulin deficiency or hyperglycemia can increase TXNIP levels in muscle, resulting in impaired peripheral glucose uptake. The pancreatic β-cell is initially able to compensate by secreting more insulin, but eventually the β-cell compensation fails. The resulting hyperglycemia may then elevate pancreatic β-cell TXNIP expression, which can induce apoptosis [40]. The loss of β-cells, in turn, results in decreased insulin production that further exacerbates peripheral IGT. The vicious cycle would eventually spiral to T2DM.](https://figures.cochat.ai/paper-figures/00021f5e308f4c0db15afac10c663543/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“RNA Isolation, Target Preparation, and Hybridization RNA from skeletal muscle biopsies for studies A and B were extracted by the guadinium thiocyanate method [11].”
MethodHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525 · cited 1×
“Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D9 values were calculated with 95% confidence intervals.”
MethodGolub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 1×
“For study A, targets from human skeletal muscle biopsies [12] were hybridized to the Affymetrix HG-U133A GeneChip (http://www.”
MethodIn silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764 · cited 1×
“To relate expression data with insulin-stimulated glucose uptake, a GEE model was used to adjust for the interdependence between twins [9,30].”
MethodBase-Calling of Automated Sequencer Traces Using Phred. I. Accuracy Assessment
Ewing, B., Hillier, L., Wendl, M. C., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.175 · Cited by 6,967 · cited 1×
“Each base was called using the PHRED software package [19,20], and quality scores were assigned.”
MethodBase-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities
Ewing, B., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.186 · Cited by 5,439 · cited 1×
“]. Genomic DNA was isolated from peripheral blood using standard procedures. We used specific primers (Applied Biosystems) to amplify the region by PCR. Sequencing was performed using Big Dye version 3.1 Cycle Sequencing kit (Applied Biosystems) according to the manufacturer's instructions, and separation was done on…”
MethodInfluential
Research works printed but not linked: 56
- Kahn, 1994, Diabetes, 43, 1066
- Eriksson, 1989, N Engl J Med, 321, 337
- Lyssenko, 2005, Diabetes, 54, 166
- Martin, 1992, Lancet, 340, 925
- Groop, 1996, Diabetes, 45, 1585
- Roden, 2005, Int J Obes, 2, S111
- Shulman, 2000, J Clin Invest, 106, 171
- Eriksson, 1990, Diabetologia, 33, 526
- Ling, 2004, J Clin Invest, 114, 1518
- Poulsen, 2005, Diabetes, 54, 275
- Chomczynski, 1987, Anal Biochem, 162, 156
- Golub, 1999, Science, 286, 531
- Wabitsch, 2001, Int J Obes Relat Metab Disord, 25, 8
- Al-Khalili, 2003, Cell Mol Life Sci, 60, 991
- Rubin, 1977, J Biol Chem, 252, 3554
- Al-Khalili, 2003, Biochem Biophys Res Commun, 307, 127
- Yoshioka, 2004, Circulation, 109, 2581
- Mootha, 2003, Nat Genet, 34, 267
- Ewing, 1998, Genome Res, 8, 186
- Ewing, 1998, Genome Res, 8, 175
- Staden, 1996, Mol Biotechnol, 5, 233
- de Bakker, 2005, Nat Genet, 37, 1217
- Florez, 2004, Diabetes, 53, 3313
- Purcell, 2003, Bioinformatics, 19, 149
- McClintick, 2006, BMC Bioinformatics, 7, 49
- Tusher, 2001, Proc Natl Acad Sci U S A, 98, 5116
- Patti, 2003, Proc Natl Acad Sci U S A, 100, 8466
- Yechoor, 2002, Proc Natl Acad Sci U S A, 99, 10587
- Yechoor, 2004, Proc Natl Acad Sci U S A, 101, 16525
- Zeger, 1986, Biometrics, 42, 121
- Zandbergen, 2005, Biochem J, 392, 313
- Phan, 2004, Nature, 432, 635
- Lee, 2003, Science, 302, 453
- Nishiyama, 1999, J Biol Chem, 274, 21645
- Shalev, 2002, Endocrinology, 143, 3695
- Hirota, 2002, J Biol Chem, 277, 44244
- Kobayashi, 2003, Kidney Int, 64, 1632
- Schulze, 2004, J Biol Chem, 279, 30369
- Hansen, 2004, Biochem Biophys Res Commun, 323, 685
- Minn, 2005, Endocrinology, 146, 2397
- Wolfrum, 2003, Proc Natl Acad Sci U S A, 100, 11624
- Elbein, 1999, Diabetes, 48, 1175
- Vionnet, 2000, Am J Hum Genet, 67, 1470
- Donnelly, 2004, J Nutr, 134, 1475
- Sheth, 2005, J Lipid Res, 46, 123
- Brownlee, 2001, Nature, 414, 813
- Houstis, 2006, Nature, 440, 944
- Petersen, 2003, Science, 300, 1140
- Wang, 2006, Oncogene, 25, 1903
- Han, 2003, Oncogene, 22, 4035
- DeFronzo, 2004, Med Clin North Am, 88
- Bonner-Weir, 2000, Trends Endocrinol Metab, 11, 375
- Poitout, 2002, Endocrinology, 143, 339
- Zierath, 2003, Best Pract Res Clin Endocrinol Metab, 17, 385
- Barrett, 2005, Bioinformatics, 21, 263
- Furuyama, 2000, Biochem J, 349, 629
Cited by
Items 201–300 of 499
NALP3 inflammasome activation in protein misfolding diseases
Shi, F., Kouadir, M., & Yang, Y. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.05.011 · Cited by 45
MondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells
Richards, P., Rachdi, L., Oshima, M., Marchetti, P., Bugliani, M., Armanet, M., Postic, C., Guilmeau, S., & Scharfmann, R. (2017) · Diabetes · doi:10.2337/db17-0595 · Cited by 48
“ARRDC4 and TXNIP both control glucose uptake in skeletal muscle cells (21,22).”
BackgroundLi, F., Okreglicka, K. M., Pohlmeier, L. M., Schneider, C., & Kopf, M. (2020) · The EMBO Journal · doi:10.15252/embj.2019103205 · Cited by 44
“In contrast, Txnip, a negative regulator of glucose uptake and cell proliferation (Parikh et al , 2007; Muri et al , 2018), was increased in pM Φ (Figs 6C and D, and EV5B).”
Ahmed, O. M., El-Twab, S. M. A., Al-Muzafar, H. M., Amin, K. A., Aziz, S. M. A., & Abdel‐Gabbar, M. (2020) · Veterinary Medicine and Science · doi:10.1002/vms3.389 · Cited by 51
“The progression of T2DM includes the development of impaired glucose tolerance, reduced tissue insulin sensitivity and eventual dysfunction of β-cells in the pancreatic islets (Cersosimo et al., 2000; Parikh et al., 2007).”
BackgroundKim, Y., Rouse, M. D., González‐Mariscal, I., Egan, J. M., & O’Connell, J. F. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0377-0 · Cited by 40
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes
Khurana, I., Kaipananickal, H., Maxwell, S., Birkelund, S., Syreeni, A., Forsblom, C. M., Okabe, J., Ziemann, M., Kaspi, A., Rafehi, H., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci160959 · Cited by 41
“They include functional connectivity with blood glucose in diabetes: TXNIP (58–61), TTC7B (62), ANKS3 (63), chromatin determinants ARID5B and CUX1 (48), islet autoantigen PTPRN2 (64), and metabolic regulators HK1 (65), PFKFB3 (66), and NCOR2 (67).”
InfluentialAnderson, A., Helmering, J., Juan, T., Li, C.-M., McCormick, J., Graham, M., Baker, D. M., Damore, M. A., Véniant, M. M., & Lloyd, D. J. (2009) · PathoGenetics · doi:10.1186/1755-8417-2-1 · Cited by 40
Sverdlov, A. L., Chan, W. P. A., Procter, N. E. K., Chirkov, Y. Y., Ngo, D. T. M., & Horowitz, J. D. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.159 · Cited by 37
Katsu-Jiménez, Y., Vazquez‐Calvo, C., Maffezzini, C., Halldin, M., Peng, X., Freyer, C., Wredenberg, A., Giménez-Cassina, A., Wedell, A., & Arnér, E. S. J. (2019) · Diabetes · doi:10.2337/db18-0557 · Cited by 40
“Importantly, insulin and cellular glucose influx reciprocally regulate TXNIP expression in humans, with glucose influx upregulating TXNIP expression and insulin suppressing it (25), which is consistent with a recent study revealing that IGF-1 can suppress TXNIP expression (26).”
BackgroundResultJiang, X., Pang, Y., Zhao, S., Hao, H., Zhao, X., Du, W., Wang, Y., & Zhu, H. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00057.2019 · Cited by 37
Molecular correlates for maximal oxygen uptake and type 1 fibers
Parikh, H., Nilsson, E., Ling, C., Poulsen, P., Almgren, P., Nittby, H., Eriksson, K.-F., Vaag, A., & Groop, L. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90255.2008 · Cited by 36
“2C) and decreased after training (Supplemental Table 5); and 4) BCL6 expression because we had previously shown that its expression is influenced by insulin (24).”
BackgroundSelf-citationAnalysis of the inhibitory mechanism of d-allose on MOLT-4F leukemia cell proliferation
Hirata, Y., Saito, M., Tsukamoto, I., Yamaguchi, F., Sui, L., Kamitori, K., Dong, Y., Uehara, E., Konishi, R., Janjua, N. A., et al. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2008.12.021 · Cited by 39
Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes
Maedler, K., Dharmadhikari, G., Schumann, D., & Størling, J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_11 · Cited by 43
Thioredoxin-Interacting Protein Stimulates Its Own Expression via a Positive Feedback Loop
Chen, J., Gu, J., Xu, G., & Shalev, A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1041 · Cited by 38
Rabbani, N., & Thornalley, P. J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1268308 · Cited by 44
Thioredoxin-interacting protein and myocardial mitochondrial function in ischemia–reperfusion injury
Yoshioka, J., & Lee, R. T. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.06.007 · Cited by 40
Self-citationInsights into obesity and diabetes at the intersection of mouse and human genetics
Kebede, M. A., & Attie, A. D. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.006 · Cited by 35
“of the most glucose inducible genes in β-cells (92) and muscle (93), through the carbohydrate response element binding protein.”
BackgroundDeng, D., Chen, C., Wang, J., Luo, S., & Feng, Y. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14652 · Cited by 38
Masaki, S., Masutani, H., Yoshihara, E., & Yodoi, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039900 · Cited by 39
“TBP-2 has a variety of biological functions in cell proliferation [15], cell apoptosis [16], immune response [17,18,19], glucose and lipid metabolism [9,20,21,22,23,24].”
BackgroundChen, Y., Lin, G., Huo, J. S., Barney, D., Wang, Z., Livshiz, T., States, D. J., Qin, Z. S., & Schwartz, J. (2009) · Endocrinology · doi:10.1210/en.2009-0212 · Cited by 38
Wang, X., Han, Y., Zhang, S., Cui, N., Liu, Z., Huang, Z., Li, C., & Zheng, F. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12929 · Cited by 35
“Moreover, for history of T2DM, besides the known impact of dysglycaemia on CAD risk [45], numerous studies have also reported the effect of TXNIP protein on abnormal glucose metabolism [12, 46] and the significant associations between TXNIP SNPs and DM risk [36].”
BackgroundThe α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer
Wedegaertner, H., Pan, W., Gonzalez, C. G., Gonzalez, D. J., & Trejo, J. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0193 · Cited by 36
“Furthermore, elevated TXNIP expression is associated with type 2 diabetes (53), suggesting that TXNIP regulates glucose metabolism.”
Obesity disrupts the pituitary-hepatic UPR communication leading to NAFLD progression
Qian, Q., Li, M., Zhang, Z., Davis, S. W., Rahmouni, K., Norris, A. W., Cao, H., Ding, W., Hotamışlıgil, G. S., & Yang, L. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.014 · Cited by 35
The inflammatory effect of epigenetic factors and modifications in type 2 diabetes
Akbari, M., & Hassan‐Zadeh, V. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00663-9 · Cited by 35
“DNA methylation percentage decreases in the 3′ UTR of thioredoxin-interacting protein (TXNIP) gene and TXNIP expression is upregulated in skeletal muscle of patients with T2D (Dayeh et al. 2016; Parikh et al. 2007).”
BackgroundBédarida, T., Baron, S., Vibert, F., Ayer, A., Henrion, D., Thioulouse, E., Marchiol, C., Beaudeux, J., Cottart, C., & Nivet‐Antoine, V. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv071 · Cited by 34
Sharma, N., Sajuthi, S. P., Chou, J. W., Calles-Escandón, J., Demons, J. L., Rogers, S. D., Ma, L., Palmer, N. D., McWilliams, D. R., Beal, J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3336 · Cited by 38
Evolutionarily Conserved Role of Thioredoxin Systems in Determining Longevity
AlOkda, A., & Raamsdonk, J. M. V. (2023) · Antioxidants · doi:10.3390/antiox12040944 · Cited by 36
“Secondly, the increased and overexpressed TXNIP, as seen in response to factors such as disturbed flow and high glucose [58,59], results in a reduction in the thioredoxin system activity.”
BackgroundType 2 diabetes mellitus and neurodegenerative disorders: The mitochondrial connection
Baduini, I. R., Castro-Vildosola, J., Kavehmoghaddam, S., Kiliç, F., Nadeem, S. A., Nizama, J. J., Rowand, M. A., Annapureddy, D., Bryan, C.-A., Do, L. H., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107439 · Cited by 33
Glutamine, Glucose and other Fuels for Cancer
Ruiz-Pérez, M. V., Sánchez‐Jiménez, F., Alonso, F. J., Segura, J., Márquez, J., & Medina, M. Á. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990482 · Cited by 35
Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
Zatterale, F., Raciti, G. A., Prevenzano, I., Leone, A., Campitelli, M., Rosa, V. D., Bèguinot, F., & Parrillo, L. (2022) · Biomolecules · doi:10.3390/biom12070982 · Cited by 33
“IL-β1 mRNA production and its accumulation in the adipose tissue are also dependent on a glucose-induced activation of the TXNIP (Thioredoxin Interacting Protein) gene, which is a regulator of peripheral glucose metabolism in humans [46,47].”
BackgroundRani, S., Mehta, J. P., Barron, N., Doolan, P., Jeppesen, P. B., CLYNES, M. M., & O’Driscoll, L. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315086 · Cited by 30
Myers, R. B., Fomovsky, G. M., Lee, S., Tan, M., Wang, B. F., Patwari, P., & Yoshioka, J. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00051.2016 · Cited by 32
Domingues, A., Boisson‐Vidal, C., Marquet, P., Dizier, B., Sadoine, J., Mignon, V., Vessières, E., Henrion, D., Escriou, V., Bigey, P., et al. (2020) · Angiogenesis · doi:10.1007/s10456-019-09704-x · Cited by 30
Ardestani, A. D., Sauter, N. S., Paroni, F., Dharmadhikari, G., Cho, J., Lupi, R., Marchetti, P., Oberholzer, J., Kerr-Conte, J., & Maedler, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210526 · Cited by 36
RetractedDNA methylation and gene expression of TXNIP in adult offspring of women with diabetes in pregnancy
Houshmand‐Oeregaard, A. S., Hjort, L., Kelstrup, L., Hansen, N. S., Broholm, C., Gillberg, L., Clausen, T. D., Mathiesen, E. R., Damm, P., & Vaag, A. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187038 · Cited by 33
“TXNIP gene expression The decreased SAT TXNIP expression in the exposure groups differs from a previous study which demonstrated increased TXNIP expression in cultured human adipocytes in response to glucose [22].”
BackgroundResultInfluentialSelf-citationMathur, R., Hui, Q., Huang, Y., GWINN, M. L., So‐Armah, K., Freiberg, M. S., Justice, A. C., Xu, K., Marconi, V. C., & Sun, Y. V. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz023 · Cited by 29
“In prediabetes and diabetes, consistently elevated TXNIP expression in muscle cells is inversely associated with glucose uptake [11].”
BackgroundExcess dietary carbohydrate affects mitochondrial integrity as observed in brown adipose tissue
Waldhart, A. N., Muhire, B. M., Johnson, B. K., Pettinga, D., Madaj, Z., Wolfrum, E., Dykstra, H., Wegert, V., Pospisilik, J. A., Han, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109488 · Cited by 31
“This was expected because the KO tissue takes in more glucose (Figure S1A; Parikh et al., 2007; Waldhart et al., 2017).”
AMPK activator O304 improves metabolic and cardiac function, and exercise capacity in aged mice
Ericsson, M., Steneberg, P., Nyrén, R., & Edlund, H. (2021) · Communications Biology · doi:10.1038/s42003-021-02837-0 · Cited by 34
He, Y., Yu, H., Zhao, H., Zhu, H., Zhang, Q., Wang, A., Shen, Y., Xu, X., & Li, J. (2021) · BMC Genomics · doi:10.1186/s12864-021-07924-4 · Cited by 30
Yuan, J. J., Tan, J. T. M., Rajamani, K., Solly, E. L., King, E. J., Lecce, L., Simpson, P. J. L., Lam, Y. T., Jenkins, A. J., Bursill, C. A., et al. (2019) · Diabetes · doi:10.2337/db17-0926 · Cited by 30
“TXNIP is an exquisitely glucose-inducible gene that is overexpressed in the tissues of animals and humans with diabetes (19,20).”
BackgroundTumor necrosis factor induces rapid down-regulation of TXNIP in human T cells
Levring, T. B., Kongsbak‐Wismann, M., Rode, A. K. O., Al-Jaberi, F. A. H., Lopez, D. V., Met, Ö., Woetmann, A., Bonefeld, C. M., Ødum, N., & Geisler, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-53234-x · Cited by 31
Mukai, N., Nakayama, Y., Abdali, S. A., & Yoshioka, J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00174.2021 · Cited by 31
Progressive development of melanoma-induced cachexia differentially impacts organ systems in mice
Graça, F. A., Stephan, A., Wang, Y., Shirinifard, A., Jiao, J., Vogel, P., Labelle, M., & Demontis, F. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111934 · Cited by 28
“…of mice implanted with cachectic tumors, including Etnppl (which catalyzes phosphoethanolamine breakdown), Txnip (which inhibits glucose uptake 76–78 ), Lrg1 (a glucose-responsive glycoprotein that promotes apoptosis and reduces brain-derived neurotrophic factor [BDNF] signaling 79–81 ), and…”
Jo, S. H., Kim, M., Park, J. M., Kim, T. H., & Ahn, Y. (2013) · Diabetologia · doi:10.1007/s00125-013-3050-6 · Cited by 30
“TXNIP is increased in patients with type 2 diabetes mellitus [9]; however, the role of TXNIP in the liver is largely unknown.”
BackgroundInfluentialBompada, P., Atac, D., Luan, C., Andersson, R., Omella, J. D., Ottosson-Laakso, E., Wright, J. B., Groop, L., & Marinis, Y. Z. D. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.10.022 · Cited by 28
Self-citationFujita, S., Sato, D., Kasai, H., Ohashi, M., Tsukue, S., Takekoshi, Y., Gomi, K., & Shintani, T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001062 · Cited by 26
“In mammalian cells, endocytosis of the glucose transporter GLUT4 is mediated by the -arrestin, TXNIP, whose expression is up-regulated by glucose but suppressed by insulin (19, 20, 29).”
BackgroundCelastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus
Zhou, D., Li, X., Xiao, X., Wang, G., Chen, B., Song, Y., Liu, X., He, Q., Zhang, H., Wu, Q., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154634 · Cited by 26
Hong, S. Y., & Hagen, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.097 · Cited by 26
Jia-yi, T., Li, D., He, L., Qiu, X.-S., Wang, E., & Wu, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.559543 · Cited by 26
“Thioredoxin interacting protein (TXNIP), also known as vitamin D3-upregulated protein (VDUP-1) (10), negatively regulates glucose uptake of cells through a negative feedback loop (11, 12).”
BackgroundAlvim, R. D. O., Santos, P. C. J. L., Ferreira, N. S., Mill, J. G., Krieger, J. E., & Pereira, A. C. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.102 · Cited by 25
dos Santos, G. C., Zeidler, J. D., Pérez-Valencia, J. A., Silva, A. C. B. S., Poian, A. T. D., El‐Bacha, T., & Almeida, F. C. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-10006-9 · Cited by 25
Dağdeviren, S., Lee, R. T., & Wu, N. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0022 · Cited by 26
“TXNIP was found to control both insulin-dependent and insulin-independent pathways of glucose uptake in skeletal muscles in human studies (Parikh et al, 2007).”
Self-citationEffectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma
Gopal, R. K., Vantaku, V. R., Panda, A., Reimer, B. M., Rath, S. P., To, T., Fisch, A. S., Çetinbaş, M., Livneh, M., Calcaterra, M. J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0976 · Cited by 27
“…uptake with a tumor suppressor function, In line with the resistance of HCC to RAI, we observed clear downregulation in the 16 genes relevant to iodine metabolism that comprise the thyroid differentiation score (TDS), including dramatic downregulation of the sodium–iodide symporter, SLC5A5 (Fig.”
Self-citationPang, S., Hsieh, W., Chuang, C., Chao, C.-H., Weng, W., & Juang, H. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0033 · Cited by 29
“Furthermore, a recent study of genome-wild expression profiles has indicated that the human TXNIP gene is important in regulating peripheral glucose metabolism (Parikh et al. 2007).”
BackgroundPasternak, Y., Ohana, M., Biron‐Shental, T., Cohen‐Hagai, K., Benchetrit, S., & Zitman‐Gal, T. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05221-8 · Cited by 25
Hypoxia-inducible factor independent down-regulation of thioredoxin-interacting protein in hypoxia
Chai, T. F., Leck, Y. C., He, H., Yu, F., Luo, Y., & Hagen, T. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.12.033 · Cited by 28
Mandala, A., Das, N., Bhattacharjee, S., Mukherjee, B., Mukhopadhyay, S., & Roy, S. S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.168 · Cited by 29
Role of thioredoxin-interacting protein in mediating endothelial dysfunction in hypertension
Wang, R., Guo, Y., Li, L., Luo, M., Peng, L., Lv, D., Cheng, Z., Xue, Q., Wang, L., & Huang, J. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.08.008 · Cited by 24
“various endogenous and exogenous stimuli.(15,31) Saxena G et al indicated that TXNIP could be released from the nucleus and shuttle into the mitochondria to disrupt the cellular redox state in response to oxidative stress.”
BackgroundLi, X., Shao, X., Bazzano, L., Xue, Q., Koseva, B. S., Grundberg, E., Shai, I., Bray, G. A., Sacks, F. M., & Qi, L. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01084-5 · Cited by 24
“Previous investigations combining human physiology, genome-wide expression profiling, and cellular studies have shown that TXNIP was an independent determinant of glucose uptake in the human body [2].”
BackgroundPresnell, S. R., Spear, H. K., Durham, J., Riddle, T., Applegate, A., & Lutz, C. T. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000020 · Cited by 26
Diminished AMPK signaling response to fasting in thioredoxin-interacting protein knockout mice
Andres, A. M., Ratliff, E. P., Sachithanantham, S., & Hui, S. T. Y. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.042 · Cited by 28
“Txnip mutations are linked to lower plasma glucose in type 2 diabetic patients who have elevated levels of Txnip in the pancreatic b-cells [8,13].”
BackgroundOsteocalcin protects pancreatic beta cell function and survival under high glucose conditions
Kover, K. L., Yan, Y., Tong, P. Y., Watkins, D. J., Li, X., Tasch, J., Hager, M., Clements, M. A., & Moore, W. V. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.095 · Cited by 29
Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain
Cohen-Kutner, M., Khomsky, L., Trus, M., Ben-Yehuda, H., Lenhard, J. M., Liang, Y. T., Martin, T. S., & Atlas, D. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.018 · Cited by 27
Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells
Yang, W., Wang, Y., Pu, Q., Ye, S., Ma, Q., Ren, J., Zhong, G., Liu, L., & Zhu, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2376 · Cited by 24
“TXNIP is a member of the thioredoxin pathway and a tumor metastasis suppressor gene (59).”
Liu, C.-Y., Hao, Y., Yin, F., Zhang, Y. L., & Liu, J. H. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0591-9 · Cited by 24
“1 3 On the other hand, independent of its thioredoxin-binding property, overexpression of Txnip repressed cellular glucose uptake, whereas Txnip knockdown increases glucose uptake in peripheral tissues in both an insulin-dependent and an insulin-independent manner [28].”
SVMRFE based approach for prediction of most discriminatory gene target for type II diabetes
Kumar, A., Sharmila, D. J. S., & Singh, S. (2017) · Genomics Data · doi:10.1016/j.gdata.2017.02.008 · Cited by 23
“GEO Effect of insulin infusion on human skeletal muscle [33] 6 6 22,215 Sweden DGAP Human pancreatic islets from normal and Type 2 diabetic subjects (A) [18] 7 5 22,191 Caucasian and Asian DGAP Human pancreatic islets from normal and Type 2 diabetic subjects (B) [18] 7 5 22,550”
BackgroundMousa, S. A., Gallati, C., Simone, T. M., Dier, E., Yalçın, M., Dyskin, E., Sudha, T., Hanko, C., & Rebbaa, A. (2009) · Aging · doi:10.18632/aging.100035 · Cited by 24
“In support of this concept, TXNIP deficiency improved glucose uptake and attenuated diabetic symptoms in animal models [16, 22, 23].”
BackgroundRazi, O., de Moraes, C., Zamani, N., Saeidi, A., Hadjicharalambous, M., Hackney, A. C., Coso, J. D., Laher, I., & Zouhal, H. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70094 · Cited by 26
“Some studies indicate that the expression of TXNIP is upregulated in obesity [316, 317].”
Low Oxygen Levels Induce Early Luteinization Associated Changes in Bovine Granulosa Cells
Baddela, V. S., Sharma, A., Viergutz, T., Koczan, D., & Vanselow, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01066 · Cited by 26
“TXNIP is a redox sensitive signaling molecule involved in glucose metabolism (Parikh et al., 2007).”
BackgroundMultiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1
Lo, A., Holmes, K., Kamlapurkar, S., Mundt, F., Moorthi, S., Fung, I., Fereshetian, S., Watson, J., Carr, S. A., Mertins, P., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abc4520 · Cited by 21
“4 of 10 involved in both redox regulation and glucose metabolism (27, 28).”
BackgroundThe Anticancer Activity of Monosaccharides: Perspectives and Outlooks
McCallum, N., & Najlah, M. (2024) · Cancers · doi:10.3390/cancers16162775 · Cited by 21
Wong, R. W., & Hagen, T. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.070 · Cited by 21
Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention
Basnet, R., Basnet, T. B., Basnet, B. B., & Khadka, S. (2022) · Current Drug Targets · doi:10.2174/1389450123666220303092324 · Cited by 22
PPARγ and C/EBPα response to acute cold stress in brown adipose tissue
Lau, K. H., Waldhart, A. N., Dykstra, H., Avequin, T., & Wu, N. (2022) · iScience · doi:10.1016/j.isci.2022.105848 · Cited by 21
Schröder, J., Schumacher, U., & Boeckelmann, L. (2020) · Cancers · doi:10.3390/cancers12103028 · Cited by 21
“TXNIP serves in different cellular functions, especially in glucose metabolism and redox homeostasis [9,11,25,26], and had initially been implicated to play an important pathophysiological role in various diseases including diabetes, inflammation, and arteriosclerosis [21,27].”
BackgroundEffect of liraglutide on dietary lipid‐induced insulin resistance in humans
Koška, J., Lopez, L. K., D’Souza, K. M., Osredkar, T., Deer, J., Kurtz, J., Salbe, A. D., Harman, S. M., & Reaven, P. D. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13037 · Cited by 22
“TxNIP expression is elevated in skeletal muscle of humans with prediabetes and type 2 diabetes and high levels of TxNIP inhibit insulinstimulated glucose transport in vitro.(33) More recent in vitro data indicate involvement of TxNIP in lipid-induced insulin resistance in skeletal muscle.”
BackgroundHolliday, K. M., Gondalia, R., Baldassari, A., Justice, A. E., Stewart, J. D., Liao, D., Yanosky, J. D., Jordahl, K. M., Bhatti, P., Assimes, T. L., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113360 · Cited by 22
“Other highly ranked but non-FDR significant associations included those near genes that have frequently been implicated in cardiometabolic disease (e.g. CPT1A K.M. Holliday et al. Environmental Research 212 (2022) 113360 (Schlaepfer and Joshi, 2020)1 and TXNIP (Parikh et al., 2007)).”
Wang, Y., Yang, J., Wang, Y., Chen, Y., Wang, Y., Kuang, H., & Feng, X. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111824 · Cited by 23
Relationship between insulin sensitivity and gene expression in human skeletal muscle
Parikh, H. M., Elgzyri, T., Alibegovic, A. C., Hiscock, N. J., Ekström, O., Eriksson, K., Vaag, A. A., Groop, L., Ström, K., & Hansson, O. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00687-9 · Cited by 21
Self-citationLee, S.-Y., Lee, H.-S., Kim, E., Ko, J.-J., Yoon, T. K., Lee, W.-S., & Lee, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070708 · Cited by 19
Baufeld, A., Koczan, D., & Vanselow, J. (2017) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0221-6 · Cited by 21
“A direct interaction between glucose and the thioredoxin-interacting protein has been described in liver and muscle cells, whereby low TXNIP levels can improve the glucose uptake [39, 40].”
BackgroundTXNIP interaction with GLUT1 depends on PI(4,5)P2
Dykstra, H., LaRose, C., Fisk, C., Waldhart, A. N., Meng, X. M., Zhao, G., & Wu, N. (2021) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2021.183757 · Cited by 18
Eraky, S. M., Ramadan, N. M., & El‐Magd, N. F. A. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3678 · Cited by 19
“TXNIP is a redox-regulated protein that has recently attention as a potential drug target for the management of diabetes and other metabolic disorders.9 Recent studies confirmed a distinct correlation between TXNIP and the development of type 2 DM.63,64 Other stud- ies related the TXNIP gene polymorphism to hypertrigl…”
BackgroundInfluentialTranscriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
Cope, H., Elsborg, J., Demharter, S., McDonald, J. T., Wernecke, C., Parthasarathy, H., Unadkat, H., Chatrathi, M., Claudio, J., Reinsch, S. S., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00532-9 · Cited by 22
“KRT24 , involved in terminal differentiation of keratinocytes, is reported to be mainly con fi ned to stratum spinosum with slight over-expression in senescent keratinocytes 49 and has been shown to induce apoptosis of keratinocytes 66 .”
Kanari, Y., Sato, Y., Aoyama, S., & Muta, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059026 · Cited by 23
“It has been reported that Txnip expression is also suppressed in response to insulin [15] and glutamine [27], both of which stimulate the glycolytic rate.”
BackgroundChung, Y. W., Lee, J., Lee, J. Y., Ju, H. H., Lee, Y., Jee, D. H., Ko, S., & Choi, J. A. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.01.011 · Cited by 18
Knaup, J., Verwanger, T., Guttmann‐Gruber, C., Ziegler, V., Bauer, J. W., & Krammer, B. E. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01519.x · Cited by 18
Vaira, S., Friday, E., Scott, K., Conrad, S. A., & Turturro, F. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22757 · Cited by 18
Toward Precision Weight-Loss Dietary Interventions: Findings from the POUNDS Lost Trial
Qi, L., Heianza, Y., Li, X., Sacks, F. M., & Bray, G. A. (2023) · Nutrients · doi:10.3390/nu15163665 · Cited by 17
“The protein coding gene TXNIP plays a critical role in glucose metabolism and regulation of β cell function (Figure 1) [67,68].”
BackgroundO-GlcNAc Modification and Its Role in Diabetic Retinopathy
Liu, C., Dong, W., Li, J., Kong, Y., & Ren, X. S. (2022) · Metabolites · doi:10.3390/metabo12080725 · Cited by 21
“This protein is persistently elevated in diabetes [67] and subjected to O-GlcNAcylation.”
BackgroundRegulation of Normal and Neoplastic Proliferation and Metabolism by the Extended Myc Network
Prochownik, E. V. (2022) · Cells · doi:10.3390/cells11243974 · Cited by 19
“of the Glut1 and Glut4 glucose receptors encoded by SLCA1 and SLC2A4 genes [86,89].”
BackgroundMansego, M. L., de Marco, G., Ivorra, C., López‐Izquierdo, R., Morcillo, S., Rojo‐Martínez, G., González-Albert, V., Martínez, F., Soriguer, F., Martín-Escudero, J. C., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0652-4 · Cited by 20
“In addition, this antioxidant protein has been related to glucose metabolism in adipocytes and in other tissues [39–41].”
BackgroundGateva, A., Assyov, Y. S., Velikova, T. V., & Kamenov, Z. A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.056 · Cited by 19
Txnip C247S mutation protects the heart against acute myocardial infarction
Nakayama, Y., Mukai, N., Wang, B. F., Yang, K., Patwari, P., Kitsis, R. N., & Yoshioka, J. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.02.013 · Cited by 17
The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans
Sales, V., & Patti, M. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0283-8 · Cited by 22
“Overexpression of TXNIP reduces glucose uptake [64].”
BackgroundThe Function of MondoA and ChREBP Nutrient—Sensing Factors in Metabolic Disease
Ahn, B. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108811 · Cited by 18
Wu, J., Wu, Y., Zhang, X., Li, S., Lu, D., Li, S., Yang, G., & Liu, D. (2013) · Clinical Endocrinology · doi:10.1111/cen.12192 · Cited by 17
Sartor, F., Jackson, M. J., Squillace, C., Shepherd, A. I., Moore, J. P., Ayer, D. E., & Kubis, H. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0401-x · Cited by 18
“TXNIP is involved in peripheral glucose uptake inhibition, especially in skeletal muscle [11] and it is a critical regulator in glucose production in the liver [48].”
InfluentialZhou, Y., Zhou, J., Lu, X., Tan, T. Z., & Chng, W. J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4661-6 · Cited by 17
Insights into the molecular mechanisms of methylmalonic acidemia using microarray technology.
Han, L., Wu, S., Han, F., & Gu, X. (2015) · Europe PMC (PubMed Central) · Cited by 16
Metadata
- Authors
- Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., Jensen, C. B., Krook, A., Björnholm, M., Tornqvist, H., Zierath, J. R., Ridderstråle, M., Altshuler, D., Lee, R. T., Vaag, A., Groop, L. C., & Mootha, V. K.
- Affiliations
- Lund University (SE)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Karolinska Institutet (SE)
- Novo Nordisk (Denmark) (DK)
- University of Helsinki (FI)
- Corresponding author
- Groop, Leif C
- Mootha, Vamsi K
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-05-01
- Volume
- 4
- Issue
- 5
- Pages
- e158
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1858708
- OpenAlex
- W2158951820
- Cited by
- 495
- References
- 57
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 41 · 2022: 35 · 2021: 39 · 2020: 34 · 2019: 22 · 2018: 29 · 2017: 21 · 2016: 29 · 2015: 29 · 2014: 23 · 2013: 28 · 2012: 31
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- American Diabetes Association
- Burroughs Wellcome Fund
- Richard and Susan Smith Family Foundation
- European Commission
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- TXNIP, type 2 diabetes, skeletal muscle glucose uptake, peripheral glucose metabolism, insulin signaling, adipocytes, prediabetes, glucose homeostasis, insulin-independent glucose uptake, genetic association
- MeSH terms
- Animals, Blood Glucose, Carrier Proteins, Cells, Cultured, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Gene Expression Regulation, Homeostasis, Humans, Hypoglycemic Agents, Insulin, Promoter Regions, Genetic, Glucose Clamp Technique, Linkage Disequilibrium, Polymerase Chain Reaction, Adipocytes, Glucose Intolerance, Muscle, Skeletal, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Protein Array Analysis, Qb-SNARE Proteins, Proto-Oncogene Proteins c-bcl-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.